Access Bio Inc (950130) - Total Liabilities

Latest as of June 2025: ₩67.08 Billion KRW ≈ $45.46 Million USD

Based on the latest financial reports, Access Bio Inc (950130) has total liabilities worth ₩67.08 Billion KRW (≈ $45.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Access Bio Inc (950130) investment intensity to see how much of total assets are deployed in long-term investments.

Access Bio Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how Access Bio Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Access Bio Inc.

Access Bio Inc Competitors by Total Liabilities

The table below lists competitors of Access Bio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
RTG Mining Inc AU:RTG	Australia	AU$1.91 Million
Arrienda Rental Properties SOCIMI SA MC:YARP	Spain	€23.66 Million
Skardin Industrial TWO:3466	Taiwan	NT$371.46 Million
Suprema ID Inc KQ:317770	Korea	₩31.52 Billion
Airgain Inc NASDAQ:AIRG	USA	$15.81 Million
Kayseri Seker Fabrikasi AS IS:KAYSE	Turkey	TL13.18 Billion
Hil Industries Bhd KLSE:8443	Malaysia	RM171.13 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Access Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Access Bio Inc balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Access Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Access Bio Inc (2012–2024)

The table below shows the annual total liabilities of Access Bio Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩61.70 Million ≈ $41.81K	-99.94%
2023-12-31	₩104.00 Billion ≈ $70.48 Million	+49192.84%
2022-12-31	₩210.97 Million ≈ $142.97K	+60.93%
2021-12-31	₩131.10 Million ≈ $88.84K	+64.97%
2020-12-31	₩79.47 Million ≈ $53.86K	+103.73%
2019-12-31	₩39.01 Million ≈ $26.43K	-24.11%
2018-12-31	₩51.40 Million ≈ $34.83K	+11.67%
2017-12-31	₩46.03 Million ≈ $31.19K	+5.38%
2016-12-31	₩43.68 Million ≈ $29.60K	-98.97%
2015-12-31	₩4.24 Billion ≈ $2.87 Million	-59.04%
2014-12-31	₩10.35 Billion ≈ $7.01 Million	+15.08%
2013-12-31	₩8.99 Billion ≈ $6.09 Million	+21.79%
2012-12-31	₩7.38 Billion ≈ $5.00 Million	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$58.40 Million

₩86.18 Billion KRW

Market Cap Rank

#21414 Global

#1249 in Korea

Share Price

₩2450.00

Change (1 day)

-0.81%

52-Week Range

₩2020.00 - ₩2570.00

All Time High

₩29950.00